Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

MA05-President
ACCC-Cancer-Program-Guidelines-MJ09
FOSTERING EXCELLENCE IN CARE AND OUTCOMES IN PATIENTS WITH STAGE III/IV NSCLC The team included representatives from medical oncology, process improvement, pathology, information technology, billing, and administration. The team developed a process map (see decision tree figure below and on back side) and identified three potential laboratory vendors that would perform the biomarker …
1801 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE, MD 20850-3184  TEL: 301.984.9496  FAX: 301.770.1949  MOS-MISSOURI.COM ENGAGE & SUCCEED. BOARD OF DIRECTORS President Joseph J. Muscato, MD, FACP Missouri Cancer Associates President-Elect Yifan Tu, MD, PhD Saint Louis University Treasurer/ Secretary Debra Tesoro, RPh, BCOP Washington University Infusion …
ISSUES | 2022 Hospital Regulatory Update By Teri Bedard, BA, RT(R)(T), CPC On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) issued a final rule for the Hospital Outpatient Prospective Payment System (HOPPS) for CY 2022. The HOPPS Final Rule can be accessed online at: federalregister.gov/public-inspection/2021-24011/medicare-program-hospital- …
MA13-Issues
s4
s4
Looking for opportunities for professional growth and resources for process and quality improvement? ACCC offers guidance, best practices, and accredited education resources and events.
Slide 1 Aim Background RESULTS DISCUSSION Limitations References Peripheral Blood T cell responses to immunotherapy related adverse events in NSCLC patients treated with Immunotherapy Suneetha Amara, Mahvish Muzaffar, Li Yang Department off Hematology and Oncology East Carolina University Greenville, North Carolina 27858 amaras19@ecu.edu MATERIALS & METHODS …
Four More States Succeed in Push for Off-Label Reimbursement Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Four More States Succeed in Push for Off-Label Reimbursement Jamie Young …
SO10-Profile
JA02-Profile
ASCO® DIRECT Highlights 2019: Leukemias and Lymphomas Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
ASCO® DIRECT Highlights 2019: Lung Cancer Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene Corporation, Daiichi …
Federal Advocacy Access ACCC’s CY 2019 PFS Proposed Rule Summary and ACCC’s CY 2019 OPPS Proposed Rule Summary (requires login) WVOS Submits Comments on the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs On July 16, 2018, the West Virginia Oncology Society (WVOS), along with the American Society of Hematology and additional oncology state societies, submitted comments on the Health …
ASCO® DIRECT Highlights 2019: Multiple Myeloma Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene Corporation, Daiichi …
ASCO® DIRECT Highlights 2019: Melanoma & Skin Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
ASCO® DIRECT Highlights 2019: Genitourinary Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
ASCO® DIRECT Highlights 2019: Hepatobiliary/Pancreatic/Gastrointestinal Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle …